Yahoo
    Paris - Delayed Quote EUR

    DBV Technologies S.A. (DBV.PA)

    1.7000 -0.1200 (-6.59%)
    At close: October 30 at 5:35:23 PM GMT+1
    Loading Chart for DBV.PA
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading

    European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading
    PREMIUM
    MT Newswires 2d ago
    DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

    DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
    GlobeNewswire 4mo ago
    DBV Technologies (ENXTPA:DBV) Advances Peanut Patch With New Phase 3 Data And Infant Trial

    DBV Technologies (ENXTPA:DBV) Advances Peanut Patch With New Phase 3 Data And Infant Trial
    Simply Wall St. 4mo ago
    DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?

    DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?
    Zacks 4mo ago
    DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

    DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
    GlobeNewswire 4mo ago
    DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026

    DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
    GlobeNewswire 4mo ago
    DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

    DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
    GlobeNewswire 4mo ago
    DBV Technologies Announces the Results of its 2026 Combined General Meeting

    DBV Technologies Announces the Results of its 2026 Combined General Meeting
    GlobeNewswire 4mo ago
    DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy

    DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
    GlobeNewswire 4mo ago
    DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq

    DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
    GlobeNewswire 5mo ago
    DBV Technologies Reports First Quarter 2026 Financial Results

    DBV Technologies Reports First Quarter 2026 Financial Results
    GlobeNewswire 5mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: